Ferdinando Carlo Maria Cananzi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ferdinando Carlo Maria Cananzi has a total of 466 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Biondi
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
24 shared publications Laura Ruspi
Sarcoma, Melanoma and Rare Tumors Surgery Unit, IRCCS Humanitas Research Hospital, Rozzano
14 shared publicationsVittorio Quagliuolo
Department of Surgery IRCCS Humanitas Research Hospital Rozzano Italy
12 shared publicationsLaura Samà
Sarcoma, Melanoma and Rare Tumors Surgery Unit, IRCCS Humanitas Research Hospital, Rozzano
11 shared publicationsRoberto Persiani
Dipartimento Scienze Gastroenterologiche, Endocrino-Metaboliche e Nefro-Urologiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
11 shared publications- Salvatore Lorenzo Renne
Department of Biomedical Sciences, Humanitas University, Milan, Italy
11 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1909970
Minimally invasive resection of multifocal duodeno-jejunal gastrointestinal stromal tumors in neurofibromatosis type 1
Gastrointestinal Stromal Tumors (GISTs) in Neurofibromatosis Type 1 (NF-1) are typically multifocal, small-bowel-based, and wild-type for KIT and PDGFRA, so surgery remains the cornerstone of treatment. Multifocal duodeno-jejunal involvement poses technical and strategic challenges, and minimally invasive management in this setting is poorly standardized. We describe a hybrid laparoscopic–mini-open, bowel-preserving approach. Laparoscopic access via the Hasson technique with three additional trocars allows systematic small-bowel exploration. Division of the ligament of Treitz and a complete Kocher maneuver fully mobilize the duodeno-pancreatic block. Targeted lesions are exteriorized through a short Alexis-protected minilaparotomy and removed by manual full-thickness wedge resection with double-layer closure. A selective strategy is applied: only enlarging or anatomically critical lesions are resected, while subcentimeter micro-GISTs are left in situ . In a 62-year-old man with NF1 and three growing GISTs (duodenal and jejunal), all targeted lesions were resected with negative (R0) margins. Histology confirmed low-risk and no risk tumors. Recovery was uneventful aside from transient delayed gastric emptying, and the patient was recurrence-free at 12 months. This standardized, reproducible technique provides a tailored minimally invasive option for multifocal NF1-associated GISTs, preserving bowel length without compromising oncologic adequacy.
- 30 October 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1909970
Open AccessMinimally invasive resection of multifocal duodeno-jejunal gastrointestinal stromal tumors in neurofibromatosis type 1
Gastrointestinal Stromal Tumors (GISTs) in Neurofibromatosis Type 1 (NF-1) are typically multifocal, small-bowel-based, and wild-type for KIT and PDGFRA, so surgery remains the cornerstone of treatment. Multifocal duodeno-jejunal involvement poses technical and strategic challenges, and minimally invasive management in this setting is poorly standardized. We describe a hybrid laparoscopic–mini-open, bowel-preserving approach. Laparoscopic access via the Hasson technique with three additional trocars allows systematic small-bowel exploration. Division of the ligament of Treitz and a complete Kocher maneuver fully mobilize the duodeno-pancreatic block. Targeted lesions are exteriorized through a short Alexis-protected minilaparotomy and removed by manual full-thickness wedge resection with double-layer closure. A selective strategy is applied: only enlarging or anatomically critical lesions are resected, while subcentimeter micro-GISTs are left in situ . In a 62-year-old man with NF1 and three growing GISTs (duodenal and jejunal), all targeted lesions were resected with negative (R0) margins. Histology confirmed low-risk and no risk tumors. Recovery was uneventful aside from transient delayed gastric emptying, and the patient was recurrence-free at 12 months. This standardized, reproducible technique provides a tailored minimally invasive option for multifocal NF1-associated GISTs, preserving bowel length without compromising oncologic adequacy.
- 15 September 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (12) , 112127
Cutting-edge organization: A consensus-informed framework in surgical oncology
- 15 September 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (12) , 112127
Cutting-edge organization: A consensus-informed framework in surgical oncology
- Open Access
- 9 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4462
Giant Retroperitoneal Lumbar Schwannoma with Extensive Vertebral Body Erosion Managed Without Spinal Instrumentation: The Potential Role of Hounsfield Unit Assessment in Surgical Decision-Making
Background: Giant retroperitoneal schwannomas with vertebral body erosion are exceedingly rare, and the decision regarding spinal instrumentation following tumor resection remains controversial in the absence of established guidelines. A 25% vertebral body involvement threshold has been proposed as an indication for fixation, yet this criterion does not account for bone quality or the potential biological adaptation of bone to chronic mechanical loading. Case Presentation: A 56-year-old man presented with bilateral gluteal pain and urinary urgency secondary to a giant retroperitoneal lumbar schwannoma (97 × 67 mm) with 36.6% erosion of the L5 vertebral body, confirmed by CT-guided biopsy (S100+, SOX10+, Ki-67 < 5%). Despite erosion exceeding the proposed instrumentation threshold, complete tumor resection was performed via an anterior laparotomic approach without spinal fixation, based on the absence of clinical or radiological signs of instability and the integrity of the intervertebral disc and posterior ligamentous complex. Intraoperative neurophysiological monitoring guided sacrifice of the tumor-origin root. The postoperative course was uneventful, with complete resolution of symptoms and no new complaints or neurological deficits at one-year follow-up. Conclusions: Post-hoc Hounsfield Unit measurements on pre-operative CT demonstrated markedly elevated bone density at the eroded L5 vertebral body (480 HU) compared with the adjacent L4 vertebra (317 HU), consistent with compensatory sclerosis induced by chronic mechanical compression. Pre-operative HU assessment may represent a valuable, readily available adjunct to anatomical erosion criteria in the surgical decision-making process for giant schwannomas with vertebral body involvement.
- 9 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4462
Open AccessGiant Retroperitoneal Lumbar Schwannoma with Extensive Vertebral Body Erosion Managed Without Spinal Instrumentation: The Potential Role of Hounsfield Unit Assessment in Surgical Decision-Making
Background: Giant retroperitoneal schwannomas with vertebral body erosion are exceedingly rare, and the decision regarding spinal instrumentation following tumor resection remains controversial in the absence of established guidelines. A 25% vertebral body involvement threshold has been proposed as an indication for fixation, yet this criterion does not account for bone quality or the potential biological adaptation of bone to chronic mechanical loading. Case Presentation: A 56-year-old man presented with bilateral gluteal pain and urinary urgency secondary to a giant retroperitoneal lumbar schwannoma (97 × 67 mm) with 36.6% erosion of the L5 vertebral body, confirmed by CT-guided biopsy (S100+, SOX10+, Ki-67 < 5%). Despite erosion exceeding the proposed instrumentation threshold, complete tumor resection was performed via an anterior laparotomic approach without spinal fixation, based on the absence of clinical or radiological signs of instability and the integrity of the intervertebral disc and posterior ligamentous complex. Intraoperative neurophysiological monitoring guided sacrifice of the tumor-origin root. The postoperative course was uneventful, with complete resolution of symptoms and no new complaints or neurological deficits at one-year follow-up. Conclusions: Post-hoc Hounsfield Unit measurements on pre-operative CT demonstrated markedly elevated bone density at the eroded L5 vertebral body (480 HU) compared with the adjacent L4 vertebra (317 HU), consistent with compensatory sclerosis induced by chronic mechanical compression. Pre-operative HU assessment may represent a valuable, readily available adjunct to anatomical erosion criteria in the surgical decision-making process for giant schwannomas with vertebral body involvement.
- Open Access
- 3 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2715
Clinical Characteristics at the Diagnosis of New Primary Melanoma in Italy: A Multicenter Retrospective Study Before and After the COVID-19 Pandemic
Background/Objectives: During the pandemic, access to healthcare was severely disrupted, inevitably affecting melanoma diagnosis. While this was clearly evident during the pandemic itself, it is less clear whether clinical presentation has returned to baseline levels in subsequent years. Our study aimed to compare the current clinical presentation of melanoma with that in the pre-pandemic setting. Methods: We conducted a retrospective multicenter study involving Italian melanoma referral centers within the SICO network. Patients with a newly diagnosed primary cutaneous melanoma were included in the study and were grouped into four time periods: pre-pandemic (March 2019 to February 2020); pandemic (March 2021 to February 2022); the first post-pandemic year (March 2022 to February 2023); and the second post-pandemic year (March 2023 to February 2024). Our focus was on clinically relevant features at diagnosis, including Breslow thickness, ulceration, stage and sentinel lymph node status. We evaluated differences across periods using regression models that accounted for the multicenter design. Results: A total of 4938 patients were included in the study. Compared with the pre-pandemic period, melanomas diagnosed during and after the pandemic were thicker, more frequently ulcerated and more likely to be in stages II–III. The rate of sentinel lymph node positivity also increased. Notably, these patterns did not normalize over time, remaining evident even in the second post-pandemic year. The results were consistent after adjusting for age and sex. Conclusions: In this large Italian study, melanoma continues to be diagnosed at a later stage than in the pre-pandemic period. This persistent shift may reflect a combination of delayed access to care and ongoing system-level constraints. These findings emphasize the importance of restoring timely access to dermatological evaluation and reinforcing early detection strategies.
- 3 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2715
Open AccessClinical Characteristics at the Diagnosis of New Primary Melanoma in Italy: A Multicenter Retrospective Study Before and After the COVID-19 Pandemic
Background/Objectives: During the pandemic, access to healthcare was severely disrupted, inevitably affecting melanoma diagnosis. While this was clearly evident during the pandemic itself, it is less clear whether clinical presentation has returned to baseline levels in subsequent years. Our study aimed to compare the current clinical presentation of melanoma with that in the pre-pandemic setting. Methods: We conducted a retrospective multicenter study involving Italian melanoma referral centers within the SICO network. Patients with a newly diagnosed primary cutaneous melanoma were included in the study and were grouped into four time periods: pre-pandemic (March 2019 to February 2020); pandemic (March 2021 to February 2022); the first post-pandemic year (March 2022 to February 2023); and the second post-pandemic year (March 2023 to February 2024). Our focus was on clinically relevant features at diagnosis, including Breslow thickness, ulceration, stage and sentinel lymph node status. We evaluated differences across periods using regression models that accounted for the multicenter design. Results: A total of 4938 patients were included in the study. Compared with the pre-pandemic period, melanomas diagnosed during and after the pandemic were thicker, more frequently ulcerated and more likely to be in stages II–III. The rate of sentinel lymph node positivity also increased. Notably, these patterns did not normalize over time, remaining evident even in the second post-pandemic year. The results were consistent after adjusting for age and sex. Conclusions: In this large Italian study, melanoma continues to be diagnosed at a later stage than in the pre-pandemic period. This persistent shift may reflect a combination of delayed access to care and ongoing system-level constraints. These findings emphasize the importance of restoring timely access to dermatological evaluation and reinforcing early detection strategies.
- Open Access
- 15 February 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (2) , e71614
Real‐World Experience of Efficacy and Tolerability of Continuous Infusion Ifosfamide for Advanced Soft Tissue and Bone Sarcoma Patients: A Single Centre Retrospective Cohort
Background: In the absence of randomized trials, selecting second or later‐line therapies in advanced sarcoma generally hinges on histology, patient performance status, and toxicity profile. We herein report a real‐world sarcoma referral center experience on continuous infusion Ifosfamide (ciIFO), in advanced Soft tissue sarcomas (STS) and bone sarcomas (BS) patients, assessing both efficacy and toxicity profile. Methods: We retrospectively collected data of STS and BS patients treated with ciIFO (14 g/m 2 as a 14‐day continuous infusion every 4 weeks) at our Institute from January 2013 to April 2023. The analysis included patients’ demographic and clinical characteristics, pathology details, treatment history, radiological response rates (RR), and toxicities per Common Terminology Criteria for Adverse Events (CTCAE) v5. Results: Ninety eight patients were included in the analysis. Median age at diagnosis was 49 years, 61% had previously received ifosfamide (IFO) and 83% anthracycline in earlier lines of treatment. Disease control rate (DCR) was 32%, with 9 PR and 22 stable disease (SD). Synovial sarcomas had the best (DCR) (60%). No statistically significant differences in DCR were seen according to sex, previous exposure to ifosfamide‐based CT, or ciIFO treatment line. mPFS was 3.0 months; mOS was 11.2 months. ciIFO was well tolerated, with an 11% discontinuation rate and no severe renal toxicity observed. Conclusions: ciIFO showed activity across different lines of therapy, achieving a DCR of 32%, and appeared better tolerated than standard‐dose IFO regimens, even in a cohort of heavily pretreated patients (18% had an Eastern Cooperative Oncology Group performance status (ECOG PS) ≥ 2). Synovial and bone sarcoma patients derived the greatest benefit (6‐month PFS of 45% in both groups).
- 15 February 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (2) , e71614
Open AccessReal‐World Experience of Efficacy and Tolerability of Continuous Infusion Ifosfamide for Advanced Soft Tissue and Bone Sarcoma Patients: A Single Centre Retrospective Cohort
Background: In the absence of randomized trials, selecting second or later‐line therapies in advanced sarcoma generally hinges on histology, patient performance status, and toxicity profile. We herein report a real‐world sarcoma referral center experience on continuous infusion Ifosfamide (ciIFO), in advanced Soft tissue sarcomas (STS) and bone sarcomas (BS) patients, assessing both efficacy and toxicity profile. Methods: We retrospectively collected data of STS and BS patients treated with ciIFO (14 g/m 2 as a 14‐day continuous infusion every 4 weeks) at our Institute from January 2013 to April 2023. The analysis included patients’ demographic and clinical characteristics, pathology details, treatment history, radiological response rates (RR), and toxicities per Common Terminology Criteria for Adverse Events (CTCAE) v5. Results: Ninety eight patients were included in the analysis. Median age at diagnosis was 49 years, 61% had previously received ifosfamide (IFO) and 83% anthracycline in earlier lines of treatment. Disease control rate (DCR) was 32%, with 9 PR and 22 stable disease (SD). Synovial sarcomas had the best (DCR) (60%). No statistically significant differences in DCR were seen according to sex, previous exposure to ifosfamide‐based CT, or ciIFO treatment line. mPFS was 3.0 months; mOS was 11.2 months. ciIFO was well tolerated, with an 11% discontinuation rate and no severe renal toxicity observed. Conclusions: ciIFO showed activity across different lines of therapy, achieving a DCR of 32%, and appeared better tolerated than standard‐dose IFO regimens, even in a cohort of heavily pretreated patients (18% had an Eastern Cooperative Oncology Group performance status (ECOG PS) ≥ 2). Synovial and bone sarcoma patients derived the greatest benefit (6‐month PFS of 45% in both groups).
- 5 January 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (3) , 111389
Inguinal “neoligament” reconstruction after groin soft tissue sarcoma resection: A novel surgical technique
- 5 January 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (3) , 111389
Inguinal “neoligament” reconstruction after groin soft tissue sarcoma resection: A novel surgical technique
- 26 August 2025
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 69, 823
Reply – Letter to the Editor
- 26 August 2025
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 69, 823
Reply – Letter to the Editor
- Open Access
- 21 July 2025
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (9) , 2215-2232
PV-1: a novel molecular prognostic marker of distant metastases in various solid tumors
Identification of biomarkers for the hematogenous spreading of cancer cells is of paramount prognostic and therapeutic value. We showed that Plasmalemma Vesicle Associated Protein-1 (PV-1) serves as a marker of increased blood vessel permeability and is an independent predictor of colorectal cancer dissemination. This study investigates whether PV-1 can also act as a prognostic marker for distant metastases in other solid tumors. We analyzed samples from 134 patients: 30 luminal breast cancer (BC), 52 clear cell renal cell carcinoma (ccRCC), and obtained preliminary data from 52 soft tissue sarcomas (STS). A higher frequency of PV-1+ endothelial cells was significantly associated with metastatic progression in luminal BC and ccRCC. Moreover, the frequency of PV-1+ cells emerged as a significant prognostic factor for metastasis-free survival in both luminal BC and ccRCC. Further research is needed to validate PV-1’s prognostic utility, as including it at diagnosis may change the management of these patients and should allow stratification for more aggressive therapies or for closer follow-ups to promptly intervene in case of metastases development.
- 21 July 2025
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (9) , 2215-2232
Open AccessPV-1: a novel molecular prognostic marker of distant metastases in various solid tumors
Identification of biomarkers for the hematogenous spreading of cancer cells is of paramount prognostic and therapeutic value. We showed that Plasmalemma Vesicle Associated Protein-1 (PV-1) serves as a marker of increased blood vessel permeability and is an independent predictor of colorectal cancer dissemination. This study investigates whether PV-1 can also act as a prognostic marker for distant metastases in other solid tumors. We analyzed samples from 134 patients: 30 luminal breast cancer (BC), 52 clear cell renal cell carcinoma (ccRCC), and obtained preliminary data from 52 soft tissue sarcomas (STS). A higher frequency of PV-1+ endothelial cells was significantly associated with metastatic progression in luminal BC and ccRCC. Moreover, the frequency of PV-1+ cells emerged as a significant prognostic factor for metastasis-free survival in both luminal BC and ccRCC. Further research is needed to validate PV-1’s prognostic utility, as including it at diagnosis may change the management of these patients and should allow stratification for more aggressive therapies or for closer follow-ups to promptly intervene in case of metastases development.
- Open Access
- 7 July 2025
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 69, 167-176
Nutritional status in retroperitoneal sarcoma: Implication of prognostic Nutritional Index (PNI) and skeletal muscle index (SMI) on postoperative and oncological outcomes
- 7 July 2025
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 69, 167-176
Open AccessNutritional status in retroperitoneal sarcoma: Implication of prognostic Nutritional Index (PNI) and skeletal muscle index (SMI) on postoperative and oncological outcomes
- Open Access
- 28 March 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 131 (6) , 1196-1201
A New ROCK Band for Diaphragmatic Reconstruction in Retroperitoneal Sarcoma Surgery
Introduction: Complete surgical resection is the mainstay of treatment for retroperitoneal sarcomas (RPS). For primary well‐differentiated liposarcomas and dedifferentiated liposarcomas, aggressive en‐bloc resection of adjacent organs is crucial for local control. Diaphragmatic resection may be necessary in left‐sided RPS cases. While primary closure of defects is usually possible, large defects may require alternative methods such as prosthetic reconstruction. Methods: We developed an innovative technique for reconstructing diaphragmatic defects after RPS resection using a rectangular polytetrafluoroethylene band called ROCK band (robust organic composite for kinetic restoration of the diaphragm). This technique involves fixing the folded band to the prevertebral fascia and diaphragm to ensure tension‐free closure while preserving diaphragm function. The study analyzed patients treated with this technique at IRCCS‐Humanitas Research Hospital from January to December 2023. Results: Four patients underwent left RPS resection with ROCK band reconstruction. The median age was 56.5 years, with a male/female ratio of 1/3. Median tumor size was 24.5 cm, and median operative time was 409.5 min. There were no ROCK band‐related complications, diaphragmatic hernias, or respiratory failures. Conclusions: This technique provides a safe, effective, and adaptable method for diaphragmatic reconstruction after RPS resection, improving anatomical and functional outcomes. Larger studies are needed for validation.
- 28 March 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 131 (6) , 1196-1201
Open AccessA New ROCK Band for Diaphragmatic Reconstruction in Retroperitoneal Sarcoma Surgery
Introduction: Complete surgical resection is the mainstay of treatment for retroperitoneal sarcomas (RPS). For primary well‐differentiated liposarcomas and dedifferentiated liposarcomas, aggressive en‐bloc resection of adjacent organs is crucial for local control. Diaphragmatic resection may be necessary in left‐sided RPS cases. While primary closure of defects is usually possible, large defects may require alternative methods such as prosthetic reconstruction. Methods: We developed an innovative technique for reconstructing diaphragmatic defects after RPS resection using a rectangular polytetrafluoroethylene band called ROCK band (robust organic composite for kinetic restoration of the diaphragm). This technique involves fixing the folded band to the prevertebral fascia and diaphragm to ensure tension‐free closure while preserving diaphragm function. The study analyzed patients treated with this technique at IRCCS‐Humanitas Research Hospital from January to December 2023. Results: Four patients underwent left RPS resection with ROCK band reconstruction. The median age was 56.5 years, with a male/female ratio of 1/3. Median tumor size was 24.5 cm, and median operative time was 409.5 min. There were no ROCK band‐related complications, diaphragmatic hernias, or respiratory failures. Conclusions: This technique provides a safe, effective, and adaptable method for diaphragmatic reconstruction after RPS resection, improving anatomical and functional outcomes. Larger studies are needed for validation.